Table 2. Patient characteristics for the retrospective cases of patients treated with osimertinib.

Abbreviations: 1L, first line; 2L, second line; 3L, third line; MSKCC, Memorial Sloan Kettering Cancer Center; NSCLC, non‐small cell lung cancer; NTUH, National Taiwan University Hospital.